9 Results for "

generalized epilepsy

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "generalized epilepsy" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-14948
CAS No.: 194085-75-1
Purity:  99.77%
Synonyms: RWJ-333369
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Carisbamate (RWJ-333369) is an orally active neuromodulator. Carisbamate prevents the development and production of epilep-like discharges and has a neuroprotective effect after in vitro epilepticus-like injury. Carisbamate has good antiepileptic activity in genetic models of generalized and nonconvulsive epilepsy .
loading...
    loading...
Cat. No.: HY-112723
CAS No.: 1838651-58-3
Purity:  99.83%
Synonyms: ACT-709478
Target:  

Calcium Channel

Research Areas:  

Neurological Disease

Apinocaltamide (ACT-709478) is a potent, selective, orally active, and brain penetrating T-type calcium channel blocker. ACT-709478 is used in the research of generalized epilepsies .
loading...
    loading...
Cat. No.: HY-B1112
CAS No.: 333-36-8
Synonyms: Bis(2,2,2-trifluoroethyl) ether; Flurothyl
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Fluorothyl (Bis (2,2,2-trifluoroethyl) ether; Flurothyl) is a GABAA receptor modulator and epileptogenic agent. Fluorothyl induces generalized epilepsy in mice. Fluorothyl is used for epilepsy research .
loading...
    loading...
Cat. No.: HY-159819
CAS No.: 2392951-18-5
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Vormatrigine is an orally active sodium channel inhibitor with anti-epileptic activity. Vormatrigine can be used to study human focal and generalized epilepsy .
loading...
    loading...
Cat. No.: HY-152166
CAS No.: 1199944-04-1
Purity:  98.89%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

NaV1.2/1.6 channel blocker-1 is a potent NaV1.2/1.6 channel blocker, with IC50s of 9.8 and 24.4 μM for rNaV1.6 and hNaV1.2, respectively. NaV1.2/1.6 channel blocker-1 can be used for the research of generalized epilepsy .
loading...
    loading...
Cat. No.: HY-123681
CAS No.: 98164-11-5
Target:  

Others

Research Areas:  

Neurological Disease

R 57720 is an antiepileptic agent that exhibits dose-dependent anticonvulsant activity across multiple postnatal rat age groups. R 57720 inhibits severe generalized tonic-clonic seizures induced by Pentylenetetrazol. R 57720 can be used for epilepsy research .
loading...
    loading...
Cat. No.: HY-W707539
Synonyms: RWJ-333369-d215N
Carisbamate-d2,- 15N (RWJ-333369-d2,- 15N) is the deuterium labeled Carisbamate (HY-14948). Carisbamate (RWJ-333369) is an orally active neuromodulator. Carisbamate prevents the development and production of epilep-like discharges and has a neuroprotective effect after in vitro epilepticus-like injury. Carisbamate has good antiepileptic activity in genetic models of generalized and nonconvulsive epilepsy .
loading...
    loading...
Cat. No.: HY-171182
CAS No.: 130403-18-8
Target:  

Endogenous Metabolite

Research Areas:  

Neurological Disease

D3017 is the main metabolite of D2624, which has oral bioactivity and anti-convulsant effects. D3017 ED50 value is 1.5 mg/kg in mice, and it can be used for research on severe generalized tonic-clonic seizures (grand mal) and complex partial epilepsy .
loading...
    loading...
Cat. No.: HY-182571
CAS No.: 15437-29-3
Target:  

Chloride Channel

Research Areas:  

Neurological Disease

AK-42 is a selective CLC-2 chloride channel inhibitor with human IC50 of 17 nM and rat IC50 of 14 nM. AK-42 binds to an extracellular vestibule above the channel pore, inhibits CLC-2 currents acutely and reversibly, including with auxiliary subunit GlialCAM coexpression. AK-42 acts as a selective tool compound for acute CLC-2 function modulation to probe CLC-2 neurophysiology. AK-42 can be used for the research of leukodystrophy and idiopathic generalized epilepsies .
loading...
    loading...